The quantitative PCR (qPCR) market is projected to expand from US$ 2.57 billion in 2023 to US$ 4.82 billion by 2031, reflecting a compound annual growth rate (CAGR) of 8.2% during the period from 2023 to 2031.

qPCR, often referred to as real-time PCR, allows for the continuous monitoring of the reaction's progress as it occurs. Unlike traditional PCR, which amplifies DNA through a series of three repetitive steps?denaturation, annealing, and elongation?qPCR incorporates a fluorophore into the sample. This addition enables real-time data collection throughout the PCR process. The application of qPCR spans both diagnostic and research fields. The anticipated growth of the quantitative PCR (qPCR) market is primarily driven by advancements in qPCR technology and an increasing demand for its use in diagnosing infectious diseases. However, the high costs associated with real-time PCR systems pose a challenge to the market's expansion.

Manufacturers of PCR equipment are intensifying their efforts to develop innovative real-time PCR instruments and kits for molecular diagnostics, which is expected to create new growth opportunities within the quantitative PCR (qPCR) market.

In November 2020, Streck introduced the Zulu RT, a groundbreaking qPCR instrument that allows for the simultaneous execution of four independent experiments. This rapid, modular device can complete a 40-cycle, 6-channel, 3-step real-time PCR in under 20 minutes, making it the fastest qPCR instrument available. Its enhanced flexibility is anticipated to capture a significant market share.

In February 2022, New England Biolabs launched its first lyophilized product developed by Fluorogenics: the LyoPrime Luna Probe One-Step RT-qPCR Mix with UDG. This lyophilized master mix facilitates sensitive and linear real-time detection of target RNA sequences in a format that remains stable at room temperature.

In February 2023, Thermo Fisher unveiled real-time PCR kits in India aimed at detecting infectious diseases. The TaqPath PCR kits, produced by Applied Biosystems, are designed to provide reliable diagnostic development and testing. These kits received licensing from the Central Drugs Standard Control Organisation and are manufactured in collaboration with Mylab Discovery Solutions based in Pune, India.

In November 2023, Roche launched the LightCycler PRO System, which is based on the established technology of its previously released LightCycler Systems. This new system enhances Roche's molecular PCR testing offerings, catering to a wide range of healthcare professionals, from researchers to those diagnosing patients for infectious diseases, cancer, and other public health issues.

Such strategic initiatives by key players in the market are expected to open new avenues for the growth of the quantitative PCR (qPCR) market.

Application-Based Insights

The quantitative PCR (qPCR) market is segmented by application into research, clinical, and forensics. The clinical segment accounted for a substantial share of the qPCR market in 2023 and is anticipated to exhibit the highest CAGR during the forecast period. qPCR technologies are instrumental in detecting gene mutations, which are crucial for cancer diagnosis. Additionally, qPCR is employed in diagnosing various diseases, including both infectious and noncommunicable diseases such as diabetes.

End User-Based Insights

The quantitative PCR (qPCR) market is also categorized by end user, which includes hospitals and diagnostic centers, forensic laboratories, pharmaceutical and biotechnology companies, research laboratories and academic institutions, and clinical research organizations. The hospitals and diagnostic centers segment held a significant share of the qPCR market in 2023 and is projected to achieve the highest CAGR from 2023 to 2031. Hospitals provide advanced diagnostic and treatment options for both acute and chronic conditions, and the adoption of PCR techniques is notably higher in these settings. This trend positively impacts the growth of the quantitative PCR (qPCR) market, as hospitals are equipped with specialized scientific tools that enhance healthcare delivery.

The quantitative PCR (qPCR) market report is informed by data from reputable sources, including the World Health Organization, Global Cancer Observatory, and the Centers for Disease Control and Prevention.